Home > National Drug Code (NDC) > CYCLOPHOSPHAMIDE

CYCLOPHOSPHAMIDE - 10019-988-01 - (Cyclophosphamide)

Alphabetical Index


Drug Information of CYCLOPHOSPHAMIDE

Product NDC: 10019-988
Proprietary Name: CYCLOPHOSPHAMIDE
Non Proprietary Name: Cyclophosphamide
Active Ingredient(s): 500    mg/25mL & nbsp;   Cyclophosphamide
Administration Route(s): INTRAVENOUS; ORAL
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of CYCLOPHOSPHAMIDE

Product NDC: 10019-988
Labeler Name: Baxter Healthcare Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA012142
Marketing Category: NDA
Start Marketing Date: 19591116

Package Information of CYCLOPHOSPHAMIDE

Package NDC: 10019-988-01
Package Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-988-01) > 25 mL in 1 VIAL, SINGLE-DOSE

NDC Information of CYCLOPHOSPHAMIDE

NDC Code 10019-988-01
Proprietary Name CYCLOPHOSPHAMIDE
Package Description 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-988-01) > 25 mL in 1 VIAL, SINGLE-DOSE
Product NDC 10019-988
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Cyclophosphamide
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAVENOUS; ORAL
Start Marketing Date 19591116
Marketing Category Name NDA
Labeler Name Baxter Healthcare Corporation
Substance Name CYCLOPHOSPHAMIDE
Strength Number 500
Strength Unit mg/25mL
Pharmaceutical Classes Alkylating Activity [MoA],Alkylating Drug [EPC]

Complete Information of CYCLOPHOSPHAMIDE


General Information